DFRF4539A

· Genentech, Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DFRF4539A, covering 2016-11-02 to 2016-11-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of DFRF4539A in Patients With Relapsed or Refractory Multiple Myeloma [Phase 1]